In the medium and long term there is no clear superiority of one treatment over another. Pain during therapeutic exercise for chronic musculoskeletal pain need not be a barrier to successful outcomes.

Musculoskeletal disorders currently afflict approximately 1.71 billion individuals globally, representing a major public health and economic challenge, ...

Increasing Opportunity for Manufacturers to Develop Customised Shock Wave Therapy Devices Tailored to Specific Medical ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

MSK Doctors (03300010048), a London-based private practice that specialises in treatments for musculoskeletal disorders, has released a new ...

This article discusses musculoskeletal pain, its potential causes, and treatment options. Musculoskeletal pain is typically localized to the body part affected by an injury or disease. In addition ...

Onabotulinumtoxin A is under clinical development by AbbVie and currently in Phase III for Unspecified Musculoskeletal Disorders.

The Department for Work and Pensions (DWP) has launched a new scheme to fast-track treatment for people with musculoskeletal (MSK) conditions, such as issues with backs, joints, and muscles ...

The Department for Work and Pensions (DWP) has announced that people with back, joint, and muscle issues living in areas with ...

The Department for Work and Pensions (DWP) has launched a new scheme to fast-track treatment for people with musculoskeletal (MSK) conditions, targeting areas with the longest waiting times.